Literature DB >> 25201260

HDL2-cholesterol/HDL3-cholesterol ratio was associated with insulin resistance, high-molecular-weight adiponectin, and components for metabolic syndrome in Japanese.

Kengo Moriyama1, Masako Negami1, Eiko Takahashi2.   

Abstract

AIMS: Recent data have suggested a relationship between the high-density lipoprotein (HDL) subclass ratio and metabolic syndrome (MetS). However, limited information is available regarding the relationships between the HDL subclass ratio and insulin resistance, associated adipocytokine levels, and MetS components. The associations of the high-density lipoprotein 2 cholesterol (HDL2-C) to high-density lipoprotein 3 cholesterol (HDL3-C) ratio with the homeostasis model assessment of insulin resistance (HOMA-IR) index, high-molecular-weight adiponectin (HMW-Ad) levels, and MetS components were examined.
METHODS: The study included 1155 Japanese subjects who met our inclusion criteria and underwent an annual health examination that included an HDL subclass analysis.
RESULTS: The HDL2-C/HDL3-C ratio and the HMW-Ad level gradually decreased as the number of MetS components increased. In contrast, HOMA-IR gradually increased as the number of MetS components increased. The HDL2-C/HDL3-C ratio correlated inversely with HOMA-IR and positively with the HMW-Ad level. A strong positive correlation was observed between the HDL2-C/HDL3-C ratio and the HDL-C level. The HDL2-C/HDL3-C ratio exhibited moderate negative correlations with the body mass index, waist circumference, and triglyceride level. Weak negative correlations were observed for the HDL2-C/HDL3-C ratio with the systolic and diastolic blood pressure and fasting plasma glucose levels.
CONCLUSIONS: Our data indicated that the HDL2-C/HDL3-C ratio was associated with insulin resistance, the HMW-Ad level, and MetS components, and it was useful for evaluating MetS in Japanese individuals.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  HDL subtypes; HDL(2)-C/HDL(3)-C ratio; High-molecular-weight adiponectin; Insulin resistance; Metabolic syndrome

Mesh:

Substances:

Year:  2014        PMID: 25201260     DOI: 10.1016/j.diabres.2014.08.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  Association of high-density lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults.

Authors:  Xiangtong Liu; Lixin Tao; Kai Cao; Zhaoping Wang; Dongning Chen; Jin Guo; Huiping Zhu; Xinghua Yang; Youxin Wang; Jingjing Wang; Chao Wang; Long Liu; Xiuhua Guo
Journal:  BMC Public Health       Date:  2015-04-22       Impact factor: 3.295

2.  Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.

Authors:  Eiichiro Kanda; Masumi Ai; Mitsuyo Okazaki; Masayuki Yoshida; Yoshitaka Maeda
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

3.  Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis.

Authors:  Wen-Chin Lee; Jin-Bor Chen; Sin-Hua Moi; Cheng-Hong Yang
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

4.  Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis.

Authors:  Tadeja Poropat Flerin; Mojca Božič Mijovski; Borut Jug
Journal:  Dis Markers       Date:  2022-08-30       Impact factor: 3.464

Review 5.  High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties.

Authors:  Teja Klancic; Lavinia Woodward; Susanna M Hofmann; Edward A Fisher
Journal:  Mol Metab       Date:  2016-03-18       Impact factor: 7.422

6.  High Molecular Weight Adiponectin Levels are Neither Influenced by Adiponectin Polymorphisms Nor Associated with Insulin Resistance in Mixed-ancestry Hyperglycemic Subjects from South Africa.

Authors:  Annalise E Zemlin; Tandi E Matsha; Andre P Kengne; Gloudina Hon; Rajiv T Erasmus
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

7.  Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study.

Authors:  Xiao-Rong Wang; Gui-Rong Song; Meng Li; Hong-Ge Sun; Yong-Jun Fan; Ying Liu; Qi-Gui Liu
Journal:  BMJ Open       Date:  2018-05-09       Impact factor: 2.692

Review 8.  Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.

Authors:  Diego Estrada-Luna; María Araceli Ortiz-Rodriguez; Lizett Medina-Briseño; Elizabeth Carreón-Torres; Jeannett Alejandra Izquierdo-Vega; Ashutosh Sharma; Juan Carlos Cancino-Díaz; Oscar Pérez-Méndez; Helen Belefant-Miller; Gabriel Betanzos-Cabrera
Journal:  Molecules       Date:  2018-10-23       Impact factor: 4.411

9.  Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension.

Authors:  You Cheol Hwang; Wilfred Y Fujimoto; Steven E Kahn; Donna L Leonetti; Edward J Boyko
Journal:  Diabetes Metab J       Date:  2018-09-28       Impact factor: 5.376

10.  HDL Subclass Analysis in Predicting Metabolic Syndrome in Koreans With High HDL Cholesterol Levels.

Authors:  Hyun Suk Yang; Mina Hur; Hanah Kim; Sun Jong Kim; Sojung Shin; Salvatore Di Somma
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.